NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » Contract Research Orgs » Sundia MediTech Company,Ltd. back to previous page show list
Sundia MediTech Company,Ltd. »31/10/2008 [Company watch]
Sundia Named To Deloitte Fast 50 China

Sundia MediTech Company, a Shanghai CRO, was included in the Deloitte Technology Fast 50 China list, placing number 16. It was the second year in a row that Sundia was given the Fast 50 award. As a Fast 50 winner, Sundia will automatically be put in contention for the Deloitte Fast 500 Asia Pacific competition.

 

Sundia MediTech Company, a Shanghai CRO, was included in the Deloitte Technology Fast 50 China list, placing number 16. It was the second year in a row that Sundia was given the Fast 50 award. As a Fast 50 winner, Sundia will automatically be put in contention for the Deloitte Fast 500 Asia Pacific competition.

Dr. Xiaochuan Wang, CEO of Sundia, saw the award as “a recognition of Sundia’s achievement” and very graciously also said it reflected well on the development of China’s entire CRO sector.

Last year, Sundia merged with another Shanghai-Based CRO, United Pharmatech Company, and it also joined the CRO Service Alliance of Shanghai (CROSSA), which now includes HD Biosciences and Tigermed. Originally focused on chemistry, Sundia currently offers most drug discovery and pharmaceutical development services. Sundia was founded in 2004.

To be considered for the Fast 50 list, a company must have its own IP or proprietary technology, have a five-year business history with base revenues of $50,000 and current revenues of at least $5 million, and submit audited financial statements.

In July, Sundia was named to Zero2IPO’s Venture 50 list for the second time. The Venture 50 list is comprised of the companies that VCs expect to provide the greatest return on investment for venture capital. Sundia completed a B financing round in December 2007.


AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.